Company: OPGN
Filing Date: 2025-10-01
Form Type: 10-Q
Source: 0001829126-25-007819
Chunk: 3

Company: OPGEN INC
Filing Date: 2025-10-01
Form: 10-Q
Item: Part I, Item 1
Chunk 3
---
100,713

    250

    $
    2

    $
    300,862,143

    $
    -

    $
    (293,908,655
    )
     
    $
    7,054,203

See accompanying notes to unaudited condensed consolidated financial statements.

3

OpGen, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(unaudited)

    Three Months Ended March 31,

    2025

    2024

    (As Restated)

    Cash flows from operating activities:

    Net (loss) income
     
    $
    (408,133
    )
     
    $
    287,967

    Adjustments to reconcile net (loss) income to net cash used in operating activities:

    Depreciation and amortization

    45,970

    42,235

    Change in inventory reserve

    -

    (13,240
    )
  
    Stock compensation expense

    81,708

    188,237

    Loss on deconsolidation of subsidiaries

    -

    75,138

    Change in fair value of EIB loan guaranty

    -

    46,584

    Gain on impairment adjustment

    -

    (2,079,575
    )
  
    Changes in operating assets and liabilities:

    Accounts receivable

    (4,838
    )

    65,348

    Inventory

    -

    13,240

    Prepaid expenses and other current assets

    217,677

    97,622

    Intangible assets

    (12,500
    )

    -

    Accounts payable

    66,441

    80,426

    Accrued compensation and benefits

    (43,197
    )

    (79,773
    )
  
    Accrued liabilities

    (10,535
    )

    243,110

    Short-term insurance financing

    (90,278
    )

    -

    Operating lease liabilities

    (40,187
    )

    (34,014
    )
  
    Deferred revenue

    -

    (17,355
    )
  
    Net cash used in operating activities

    (197,872
    )

    (1,084,050
    )

    Cash flows from investing activities:

    Purchases of property and equipment

    -